Michael Gelband’s Nuvalent NUVL Stock Holding History

Michael Gelband’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.5M	Buy	+360,000	New	+$38.7M	0.29%	49

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Michael Gelband's NUVL Position: Q2 2026 in Review

Michael Gelband reduced its Nuvalent (NUVL) stake by 93% in Q2 2026, selling an estimated $6.35M and leaving 4,712 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Michael Gelband first reported a position in NUVL in Q2 2024 and has held it in 4 quarters since. The position peaked at $6.53M in Q1 2026. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Michael Gelband held 4,712 shares of Nuvalent worth $582K as of Q2 2026.
Michael Gelband sold 59,008 Nuvalent shares in Q2 2026, an estimated $6.35M.
Nuvalent made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1199 holding.
Michael Gelband first reported a position in Nuvalent in Q2 2024 and has held it in 4 quarters since.
Michael Gelband's Nuvalent position peaked at $6.53M in Q1 2026.
287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.